ZACKSยท2025-09-29 19:16Core Insights - Alexandria Real Estate Equities, Inc. (ARE) has opened Lilly Gateway Labs at One Alexandria Square Megacampus in San Diego, enhancing its commitment to supporting biotechnology innovation [1][6] - The partnership with Eli Lilly combines Alexandria's real estate expertise with Lilly's scientific resources and venture capital access [2][6] - The new lab aims to support the development of transformative treatments for various diseases, building on the success of previous Gateway Labs in South San Francisco and Boston [3][7] Company and Industry Summary - Lilly Gateway Labs in San Diego is designed to foster collaboration among biotech companies focusing on Alzheimer's, Parkinson's, cardiovascular, metabolic diseases, and oncology [5][7] - The facility features modular lab spaces, advanced scientific amenities, and operational support, enhancing the research environment for resident companies [5][6] - Alexandria has been developing the life science ecosystem in San Diego since 1994, with the new lab located near prominent research institutions, facilitating collaboration opportunities [4][6] - Over the past three months, Alexandria's shares have increased by 15.4%, outperforming the industry growth of 1.7% [6]